Virax Biolabs Correlations

VRAX Stock  USD 0.82  0.05  5.75%   
The correlation of Virax Biolabs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Virax Biolabs Correlation With Market

Good diversification

The correlation between Virax Biolabs Group and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and DJI in the same portfolio, assuming nothing else is changed.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virax Biolabs Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Moving together with Virax Stock

  0.65EQ EquilliumPairCorr
  0.75DRMA Dermata TherapeuticsPairCorr
  0.75DRUG Bright Minds BiosciencesPairCorr
  0.74VIVS VivoSim Labs, Symbol ChangePairCorr
  0.66VTGN VistaGen TherapeuticsPairCorr

Moving against Virax Stock

  0.5VIGL Vigil NeurosciencePairCorr
  0.4VERV Verve Therapeutics TrendingPairCorr
  0.49EDIT Editas MedicinePairCorr
  0.44VRNA Verona Pharma PLCPairCorr
  0.43VTYX Ventyx BiosciencesPairCorr
  0.38VRCA Verrica PharmaceuticalsPairCorr
  0.38ELEV Elevation OncologyPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
BDRXREVB
BDRXCDIO
CDIOREVB
ALLRKPRX
ALLRREVB
ALLRCDIO
  
High negative correlations   
QNRXREVB
CDIOQNRX
BDRXQNRX
BDRXKPRX
KPRXREVB
CDIOKPRX

Risk-Adjusted Indicators

There is a big difference between Virax Stock performing well and Virax Biolabs Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Virax Biolabs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BWV  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
REVB  5.13 (1.57) 0.00  2.79  0.00 
 6.90 
 90.57 
HILS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
KPRX  3.08  0.15  0.03  10.37  4.15 
 5.23 
 55.05 
QNRX  4.91  0.01  0.00 (0.21) 6.53 
 10.79 
 58.59 
NRBO  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CDIO  7.22 (1.42) 0.00 (11.66) 0.00 
 13.59 
 64.52 
ALLR  4.38  0.01  0.00  0.04  4.53 
 9.57 
 25.55 
KRBP  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
BDRX  5.46 (0.74) 0.00  1.03  0.00 
 12.74 
 51.41 

Virax Biolabs Corporate Management

Tomasz GeorgeChief OfficerProfile
Joel YeungAccounting ManagerProfile
Nigel MScChief OfficerProfile
Cameron ShawCOO DirectorProfile
James WangHead SourcingProfile
James FosterChairman CEOProfile